Hj. Kruse et al., DISSOCIATION OF RENIN AND ALDOSTERONE DURING LOW-DOSE EPINEPHRINE INFUSION, American journal of hypertension, 7(10), 1994, pp. 913-918
Besides its dose-dependent alpha- and beta-adrenoceptor-mediated vascu
lar action, hormonal effects of epinephrine also involve the activatio
n of renin secretion by direct stimulation of renal beta(1)-adrenocept
ors. To determine the interrelation between increased plasma renin act
ivity in response to epinephrine and plasma aldosterone concentration
and renal excretion of potassium and sodium, 26 normal subjects were s
ubjected to 4 h of an intravenous infusion of low-dose epinephrine (12
ng/kg/min). Epinephrine infusion raised mean plasma epinephrine conce
ntration 2.8-fold above control (P < .001). Plasma renin activity (PRA
) increased by 56% (P < .01) during epinephrine infusion, whereas plas
ma aldosterone concentration remained constant. Infusion of epinephrin
e also resulted in markedly suppressed urinary potassium excretion (-3
2%; P < .025), while urinary sodium excretion was not altered. Serum p
otassium was decreased by 4.1% during epinephrine (P < .025). Systolic
blood pressure and heart rate did not change, and diastolic blood pre
ssure was slightly reduced by 5 mm Hg (P < .025). In summary, during l
ow-dose epinephrine infusion PRA is markedly increased while plasma al
dosterone remains unchanged. The fall in urinary potassium excretion i
n the presence of reduced serum potassium concentration is most likely
mediated via the beta-adrenoceptor-mediated shift of potassium into c
ells. This in turn may prevent a concomitant rise of plasma aldosteron
e, which subsequently contributes to the blunted kaliuresis and unchan
ged natriuresis found during the epinephrine-induced rise of PRA. In c
onclusion, the epinephrine-induced fall in serum potassium appears to
be the predominant regulator of plasma aldosterone concentration even
in the presence of a stimulated PRA.